Skip to main content
Clinical Trials/ISRCTN68599804
ISRCTN68599804
Completed
未知

Safety and Effectiveness using DEXmedetomidine sedation versus propofol/alfentanil sedation during oesophagus interventions

Academic Medical Centre (AMC) (Netherlands)0 sites64 target enrollmentApril 16, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Academic Medical Centre (AMC) (Netherlands)
Enrollment
64
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 16, 2013
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Academic Medical Centre (AMC) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • Eligible patients for participation in this clinical trial are those planned to undergo elective endoscopic oesophagus intervention. The patients must comply with the following criteria in order to be eligible to participate in this clinical study:
  • 1\. Male and female, age range \= 18 years without upper age limit
  • 2\. ASA classification I ? III
  • 3\. Written informed consent

Exclusion Criteria

  • 1\. Age range \< 18 years
  • 2\. ASA classification IV and V
  • 3\. Allergic reaction to planned medication in the patients? medical history
  • 4\. Unregulated hypertension
  • 5\. Hypovolemia or hypotension (systolic blood pressure \<80 or mean arterial pressure \<50 mmHg)
  • 6\. Severe bradycardia (heart rate \< 50/min) and / or related brady\-dysrhythmias (e.g. advanced heart block)
  • 7\. Impaired ventricular function (left ventricular ejection fraction \<30%)
  • 8\. Impaired renal function, GFR less than 15ml/min or undergoing hemodialysis
  • 9\. Impaired liver function
  • 10\. Substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX)
NL-OMON35831Academisch Medisch Centrum64
Completed
Phase 4
A clinical study to find whether dexmedetomidine provides adequate comfort to patients during awake nasal fibreoptic intubatioHealth Condition 1: null- Scheduled for awake nasal fibreoptic intubation in view of assessed difficult airway
CTRI/2012/09/002948Kasturba Hospital KMC Manipal36
Not yet recruiting
Not Applicable
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgery
CTRI/2024/07/070582Dr Sridevi Mulimani
Completed
Not Applicable
To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTPHealth Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY
CTRI/2017/11/010353ALL INDIA INSTITUTE OF MEDICAL SCIENCES80
Active, not recruiting
Not Applicable
The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks (regional anesthesia) for shoulder surgeryThe goal of the present study is to investigate the safety and efficiacy of dexmedetomidine added toropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans.Provided the initial safety can be established, the trial will continue to evaluate secondary goalsincluding the duration of analgesia, onset of sensory and motor blockade, and opioid-inducedside effects. Tertiary outcomes will include activity, sleep, and subject satisfaction.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2011-002175-42-ATParacelsus Medizinische Universität - Universitätsklinik für Anästhesie